Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
Muntadhar Al Moosawi, Consultant Hematopathology and Head of Transfusion Services and Coagulation Laboratory, shared on LinkedIn:
”Honored to be a speaker at WHX Labs Dubai, where I presented on the clinical utility of the chromogenic Factor VIII assay in hemophilia A.
My talk focused on the well-recognized discrepancies between one-stage clot-based and chromogenic assays—particularly in mild and moderate hemophilia—and the practical implications for accurate diagnosis, monitoring, and therapeutic decision-making in the era of extended half-life products and novel agents.
It was a privilege to engage with colleagues and discuss how optimized assay selection and interpretation can directly impact patient care and laboratory best practices.
Thanks to the Dr. Eiman Alzaabi and Dr. Chethan Belludi for the invitation.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026